Clinical Features of Invasive Fungal Infections: Aspergillosis, Candidiasis and Mucormycosis

被引:0
|
作者
Alan, M. Servet [1 ]
机构
[1] Mem Sisli & Atasehir Hastaneleri, Infeksiyon Hastaliklari & Klin Mikrobiyol Bolumu, Istanbul, Turkey
关键词
Invasive fungal infections; aspergillosis; candidiasis; mucormycosis; MANIFESTATIONS; DIAGNOSIS;
D O I
10.5152/kd.2019.54
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Invasive fungal infection (IFI) is an important cause of morbidity and mortality especially in immunosupressed patients. They can range widely in severity; while mucocutaneous infections are more frequent, fungal infections can be life threatening in some patients. Candida and Aspergillus species are the most common causes of IFIs. Candida spp. have become important causes of sepsis in hospitals, with incidence constantly growing over the last 20 years. Invasive aspergillosis is the second most common IFI, with increasing incidence over the last two decades along with the advances in the treatment of hematological malignancies. Mucormycosis is the second most common invasive mould infection. Agents like Mucor spp. can cause devastating infections.
引用
收藏
页码:124 / 127
页数:4
相关论文
共 50 条
  • [31] Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis
    Zorica Jović
    Slobodan M. Janković
    Dejana Ružić Zečević
    Dragan Milovanović
    Srđan Stefanović
    Marko Folić
    Jasmina Milovanović
    Marina Kostić
    European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 139 - 157
  • [32] Guidelines for the treatment of invasive candidiasis and aspergillosis in adults
    Hennequin, C.
    Gauzit, R.
    Wolff, M.
    Cordonnier, C.
    ANTIBIOTIQUES, 2010, 12 (03): : 165 - 170
  • [34] Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients
    Basile, Kerri
    Halliday, Catriona
    Kok, Jen
    Chen, Sharon C-A.
    JOURNAL OF FUNGI, 2022, 8 (01)
  • [35] The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
    Ghosh, Asmita
    Sarkar, Anusua
    Paul, Pubali
    Patel, Parth
    FUNGAL BIOLOGY REVIEWS, 2021, 38 : 67 - 91
  • [36] Autopsy Diagnosis of Invasive Pulmonary Aspergillosis and Fungal Encephalitis Due to Disseminated Pulmonary Mucormycosis in a Pediatric Patient
    Nair, Anupriya S.
    Jadav, Devendra
    Shekhawat, Raghvendra Singh
    Rathore, Mohini
    Khera, Sudeep
    Sharma, Rashim
    AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY, 2023, 44 (04): : e117 - e119
  • [37] Clinical Aspects of Invasive Candidiasis Endocarditis and Other Localized Infections
    Venditti, Mario
    DRUGS, 2009, 69 : 39 - 43
  • [38] ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
    Tissot, Frederic
    Agrawal, Samir
    Pagano, Livio
    Petrikkos, Georgios
    Groll, Andreas H.
    Skiada, Anna
    Lass-Floerl, Cornelia
    Calandra, Thierry
    Viscoli, Claudio
    Herbrecht, Raoul
    HAEMATOLOGICA, 2017, 102 (03) : 433 - 444
  • [39] Clinical efficacy and safety of posaconazole for the treatment of invasive aspergillosis infections
    Ribaud, P.
    JOURNAL DE MYCOLOGIE MEDICALE, 2006, 16 : S19 - S23
  • [40] Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
    Natesan, Suganthini Krishnan
    Chandrasekar, Pranatharthi H.
    INFECTION AND DRUG RESISTANCE, 2016, 9 : 291 - 300